The gold standard is the Abnormal Involuntary Movement Scale, or the AIMS, although generally we kind of want to avoid premature TD labels, and we want to ensure that there's a causal link, in this ...

Tardive dyskinesia causes repeated, uncontrollable movements in the face and body. It is a side effect of some neuroleptic or antipsychotic medications. These medications may change dopamine activity ...

The US Food and Drug Administration (FDA) has approved the first medication for the treatment of tardive dyskinesia (TD), the agency said in a statement. "[TD] can be disabling and can further ...

Tardive dyskinesia (TD) is a rare movement disorder linked to long-term use of certain medications, especially dopamine receptor-blocking drugs like antipsychotics. Early TD symptoms often start with ...

In 2024, several research and pharmacological advancements were made for tardive dyskinesia, a movement disorder caused by dopamine-blocking medications. Below are some of the highlights of the year.

Accurate and early diagnosis of tardive dyskinesia (TD), a serious movement disorder typically caused by exposure to antipsychotic medications, is imperative for long-term management. "Keeping an eye ...